Skip to main content

Remote Job Finders (RJF)

Moonwalk pulls in $70M to take fat-targeting RNAi obesity candidate to clinic

Moonwalk Biosciences plans to shepherd its lead obesity asset into first-in-human trials in late 2027. In preclinical studies, MW101 has demonstrated weight loss and fat reduction while maintaining muscle mass.

Biotech is back, with H1 progress smoothing glide path through end of year: Truist

With M&A rising, venture capital returning and policy risks easing, biotech is on a positive trajectory following a prolonged post-pandemic slump, Truist Securities declared after a survey of sector leaders.

FDA approves Ionis’ antisense drug as first targeted therapy for Alexander disease

Zanvastro, an antisense oligonucleotide therapy, represents the first independent neurology launch for Ionis Pharmaceuticals, which intends to leverage the foothold for more approvals in rare neurodegenerative diseases, including Angelman syndrome.

Follow the money: How funding announcements can help identify jobs before they’re posted

Funding announcements can signal future hiring activity, giving biotech professionals a chance to build relationships before positions are posted. Industry experts share how to identify the funding events, milestones and company indicators most likely to lead to new jobs.
Scroll to top